Finance

Beta
Lists
CLS-B:STO
Clinical Laserthermia Systems AB
SEK 3.59
+0.28%
(+0.0100) 1D
Jun 5, 5:02:01 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CLS-B...
Open
SEK 3.60
High
SEK 3.77
Low
SEK 3.56
Mkt. cap
111.88M
Avg. vol.
131.79K
Volume
25.08K
52-wk high
SEK 13.36
52-wk low
SEK 2.60
EPS
-SEK 1.19
Shares outstanding
31.16M
No. of employees
13
Open
SEK 3.60
High
SEK 3.77
Low
SEK 3.56
Mkt. cap
111.88M
Avg. vol.
131.79K
Volume
25.08K
52-wk high
SEK 13.36
52-wk low
SEK 2.60
EPS
-SEK 1.19
Shares outstanding
31.16M
No. of employees
13
News stories
From sources across the web
About Clinical Laserthermia Systems AB
CEODan J. Mogren
Employees13
Founded2006
Headquarters-
SectorMedical device
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.36M
2.80M
830.00K
1.28M
Cost of goods sold
2.80M
1.56M
591.00K
509.00K
Cost of revenue
2.80M
1.56M
591.00K
509.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.82M
7.95M
10.30M
9.72M
Operating expense
9.49M
8.66M
11.05M
10.43M
Total operating expenses
12.29M
10.23M
11.64M
10.94M
Operating income
-2.93M
-7.43M
-10.81M
-9.66M
Other non operating income
-8.00K
-4.00K
158.00K
94.00K
EBT including unusual items
-6.35M
-8.14M
-12.33M
-7.36M
EBT excluding unusual items
-2.94M
-7.43M
-10.75M
-7.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
73.00K
107.00K
-26.00K
106.00K
Net income
-6.35M
-8.14M
-11.90M
-7.36M
Net profit margin
-67.81%
-290.71%
-1,433.98%
-577.19%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
2.21M
Interest expense
-
-
-94.00K
-
Net interest expenses
-
-
-94.00K
2.21M
Depreciation and amortization charges
604.00K
604.00K
772.00K
611.00K
EBITDA
-2.33M
-6.82M
-10.04M
-9.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more